HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,987 | +11.5% | 1,963 | +5.3% | 0.01% | +14.3% |
| Q2 2023 | $67,271 | +13.1% | 1,865 | +19.8% | 0.01% | 0.0% |
| Q1 2023 | $59,462 | -45.2% | 1,557 | -18.3% | 0.01% | -46.2% |
| Q4 2022 | $108,451 | +23.2% | 1,906 | -14.8% | 0.01% | -13.3% |
| Q3 2022 | $88,000 | -8.3% | 2,237 | +2.1% | 0.02% | -6.2% |
| Q2 2022 | $96,000 | +10.3% | 2,191 | +0.6% | 0.02% | +23.1% |
| Q1 2022 | $87,000 | -34.1% | 2,178 | -33.8% | 0.01% | -35.0% |
| Q4 2021 | $132,000 | +6500.0% | 3,288 | +7546.5% | 0.02% | +1900.0% |
| Q3 2021 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 43 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 43 | -23.2% | 0.00% | – |
| Q1 2020 | $1,000 | -92.9% | 56 | -94.4% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |